News & Events
Combinostics raises €3.9M to support early Alzheimer’s diagnosis
Combinostics is pleased to announce the closure of a €3.9M series A funding round to extend the company’s cNeuro platform in the US and Asia.
Combinostics partners with Nihon Medi-Physics to develop and market cNeuro platform in Japan
Combinostics is pleased to announce an exclusive partnership with Nihon Medi-Physics to develop and market the cNeuro platform in Japan.
Three peer-reviewed, scientific publications that describe the use of cNeuro
Three peer-reviewed, scientific journals have published articles that describe the use of the cNeuro platform for dementias and other cognitive disorders.
Combinostics selected to join the 2019 MassChallenge HealthTech cohort
Combinostics has been selected to join the 2019 MassChallenge HealthTech cohort which represents the most innovative technologies advancing health and improving the overall patient experience.
RSNA 2018
Attending RSNA 2018? Speak with one of our team members at kiosk 7367M in the North – Hall.
TechEmerge Health Brazil 2018
Combinostics has been selected to participate in the TechEmerge Health Brazil 2018.
Combinostics releases version 1.4.0 to its cNeuro suite
Combinostics is pleased to announce the release of version 1.4.0 of the cNeuro suite of tools. The upgrade provides new access to cMRI features and features improved classification algorithms in cDSI.
